Financial reports
10-Q
2024 Q2
Quarterly report
8 Aug 24
10-Q
2024 Q1
Quarterly report
8 May 24
ARS
2023 FY
Annual report to shareholders
17 Apr 24
10-Q
2023 Q3
Quarterly report
8 Nov 23
10-Q
2023 Q2
Quarterly report
9 Aug 23
10-Q
2023 Q1
Quarterly report
4 May 23
ARS
2022 FY
Annual report to shareholders
12 Apr 23
10-K
2022 FY
Annual report
22 Mar 23
10-Q
2022 Q3
Quarterly report
8 Nov 22
10-Q
2022 Q2
Quarterly report
9 Aug 22
Current reports
8-K
Other Events
23 Sep 24
8-K
Assembly Biosciences Reports Second Quarter 2024 Financial Results and Recent Updates
8 Aug 24
8-K
Assembly Biosciences Announces $12.6 Million in Equity Financings
18 Jun 24
8-K
Departure of Directors or Certain Officers
3 Jun 24
8-K
Assembly Biosciences Reports First Quarter 2024 Financial Results and Recent Highlights
8 May 24
8-K
Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent Highlights
28 Mar 24
8-K
Departure of Directors or Certain Officers
15 Mar 24
8-K
Assembly Biosciences Announces Effective Date of Reverse Stock Split
13 Feb 24
8-K
Submission of Matters to a Vote of Security Holders
2 Feb 24
8-K
Termination of a Material Definitive Agreement
17 Jan 24
Registration and prospectus
S-8
Registration of securities for employees
8 Aug 24
424B5
Prospectus supplement for primary offering
18 Jun 24
S-8
Registration of securities for employees
9 Aug 23
S-3
Shelf registration
22 Mar 23
S-8
Registration of securities for employees
9 Aug 22
S-8
Registration of securities for employees
5 Aug 21
S-8
Registration of securities for employees
28 Aug 20
S-3
Shelf registration
28 Aug 20
424B5
Prospectus supplement for primary offering
13 Dec 19
424B5
Prospectus supplement for primary offering
11 Dec 19
Proxies
DEFA14A
Additional proxy soliciting materials
17 Apr 24
DEF 14A
Definitive proxy
17 Apr 24
DEFA14A
Additional proxy soliciting materials
21 Dec 23
DEF 14A
Definitive proxy
21 Dec 23
PRE 14A
Preliminary proxy
11 Dec 23
DEFA14A
Additional proxy soliciting materials
12 Apr 23
DEF 14A
Definitive proxy
12 Apr 23
PRE 14A
Preliminary proxy
31 Mar 23
DEFA14A
Additional proxy soliciting materials
12 Apr 22
DEF 14A
Definitive proxy
12 Apr 22
Other
EFFECT
Notice of effectiveness
17 Apr 23
CORRESP
Correspondence with SEC
12 Apr 23
UPLOAD
Letter from SEC
24 Mar 23
UPLOAD
Letter from SEC
11 Feb 21
CORRESP
Correspondence with SEC
12 Jan 21
UPLOAD
Letter from SEC
29 Dec 20
EFFECT
Notice of effectiveness
8 Sep 20
CORRESP
Correspondence with SEC
3 Sep 20
UPLOAD
Letter from SEC
2 Sep 20
SEC STAFF
SEC staff action: Order
26 Feb 20
Ownership
4
Nicole S White
5 Aug 24
4
Jason A Okazaki
5 Aug 24
4
Alexander Schornstein
8 Jul 24
SC 13D/A
Schornstein Alexander
24 Jun 24
SC 13D/A
GILEAD SCIENCES, INC.
20 Jun 24
4
Change in insider ownership
20 Jun 24
4
Lisa Johnson-Pratt
30 May 24
4
John G McHutchison
30 May 24
4
Susan Mahony
30 May 24
4
Michael Houghton
30 May 24